GHS Institute of Transitional Oncology Research — Greenville, South Carolina

GHS Institute of Transitional Oncology Research is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

GHS Institute of Transitional Oncology Research has participated in 1 clinical trials.

Therapeutic areas: HER-2 Gene Amplification.

Sponsors: Merrimack Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GHS Institute of Transitional Oncology Research?

GHS Institute of Transitional Oncology Research has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GHS Institute of Transitional Oncology Research conducted?

GHS Institute of Transitional Oncology Research has 1 clinical trials on record. Their work covers HER-2 Gene Amplification.

Is GHS Institute of Transitional Oncology Research accredited by Crixeo Health?

GHS Institute of Transitional Oncology Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GHS Institute of Transitional Oncology Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.